Nano Labs Regains Compliance with Nasdaq Minimum Bid Price Requirement
20 November 2024 - 8:30AM
Nano Labs Ltd (Nasdaq: NA) (“we,” the “Company” or “Nano Labs”), a
leading fabless integrated circuit design company and product
solution provider in China, today announced that it received a
notification letter (the “Notification Letter on Compliance”) from
the Listing Qualifications Department of The Nasdaq Stock Market
Inc. (“Nasdaq”) on November 18, 2024, indicating that the Company
has regained compliance with the minimum bid price requirement set
forth in Rule 5450(a)(1) of the Nasdaq Listing Rules.
As previously announced, on May 23, 2024, the
Nasdaq notified the Company of its non-compliance with the Nasdaq’s
minimum bid price requirement due to its failure to maintain a
minimum bid price of US$1 per share. According to the
Notification Letter on Compliance, the staff of Nasdaq has
determined that for the last 10 consecutive business days, from
November 4 through November 15, 2024, the closing bid price of the
Company’s Class A ordinary shares had been at $1.00 per share or
greater, and the Company has regained compliance with Rule
5450(a)(1) of the Nasdaq Listing Rules.
About Nano Labs Ltd
Nano Labs Ltd is a leading fabless integrated
circuit (“IC”) design company and product solution provider in
China. Nano Labs is committed to the development of high throughput
computing (“HTC”) chips, high performance computing (“HPC”) chips,
distributed computing and storage solutions, smart network
interface cards (“NICs”) vision computing chips and distributed
rendering. Nano Labs has built a comprehensive flow processing unit
(“FPU”) architecture which offers solution that integrates the
features of both HTC and HPC. Nano Lab’s Cuckoo series are one of
the first near-memory HTC chips available in the market*. For more
information, please visit the Company’s website at: ir.nano.cn.
* |
According to an industry report prepared by Frost &
Sullivan. |
Forward-Looking Statements
This press release contains forward-looking
statements within the meaning of Section 21E of the Securities
Exchange Act of 1934, as amended, and as defined in the U.S.
Private Securities Litigation Reform Act of 1995. These
forward-looking statements include, without limitation, the
Company’s plan to appeal the Staff’s determination, which can be
identified by terminology such as “may,” “will,” “expect,”
“anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,”
“potential,” “continue,” “is/are likely to” or other similar
expressions. Such statements are based upon management’s current
expectations and current market and operating conditions, and
relate to events that involve known or unknown risks, uncertainties
and other factors, all of which are difficult to predict and many
of which are beyond the Company’s control, which may cause the
Company’s actual results, performance or achievements to differ
materially from those in the forward-looking statements. Further
information regarding these and other risks, uncertainties or
factors is included in the Company’s filings with the Securities
and Exchange Commission. The Company does not undertake any
obligation to update any forward-looking statement as a result of
new information, future events or otherwise, except as required
under law.
For investor inquiries, please
contact:
Nano Labs Ltdir@nano.cn
Ascent Investor Relations LLCTina XiaoPhone:
+1-646-932-7242Email: investors@ascent-ir.com
Nano Labs (NASDAQ:NA)
Historical Stock Chart
From Oct 2024 to Nov 2024
Nano Labs (NASDAQ:NA)
Historical Stock Chart
From Nov 2023 to Nov 2024